Overview

Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%

Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare thermography images in normal healthy premenopausal women after the application of Sildenafil Cream, 3.6%, L-arginine cream, and placebo cream. Participants will be shown a series of explicit videos to elicit a change in genital temperature before and after application of cream.
Phase:
Phase 1
Details
Lead Sponsor:
Daré Bioscience, Inc.
Collaborator:
Strategic Science & Technologies, LLC
Treatments:
Sildenafil Citrate